These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3291315)

  • 41. Cyclosporine nephrotoxicity: exploration of the risk factors and prognosis of the renal injury.
    Keown PA; Stiller CR; Wallace AC; McKenzie FN; Wall W
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):247-53. PubMed ID: 3895663
    [No Abstract]   [Full Text] [Related]  

  • 42. Five-year serial renal graft biopsy study in cyclosporine-treated patients.
    Wilczek H; Bohman SO; Klintmalm G; Groth CG
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):812-5. PubMed ID: 3291319
    [No Abstract]   [Full Text] [Related]  

  • 43. Cyclosporine nephrotoxicity without major organ transplantation.
    Nahman NS; Cosio FG; Kolkin S; Mendell JR; Sharma HM
    Ann Intern Med; 1987 Mar; 106(3):400-2. PubMed ID: 3544994
    [No Abstract]   [Full Text] [Related]  

  • 44. A simple and reliable way of differentiating acute rejection from cyclosporine nephrotoxicity in renal transplantation.
    Oh CS; Stratta RJ; Pirsch JD; Sollinger HW; Kalayoglu M; Belzer FO
    Transplantation; 1988 Aug; 46(2):311-2. PubMed ID: 3043781
    [No Abstract]   [Full Text] [Related]  

  • 45. Nephrotoxicity in patients with rheumatoid arthritis treated with cyclosporine.
    Ludwin D; Bennett KJ; Grace EM; Buchanan WW; Bensen W; Bombardier C; Tugwell PX
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):367-70. PubMed ID: 3381299
    [No Abstract]   [Full Text] [Related]  

  • 46. Cyclosporine, azathioprine, and prednisone as treatment for cyclosporine-induced nephrotoxicity in renal transplant recipients.
    Lorber MI; Flechner SM; Van Buren CT; Kerman RH; Kahan BD
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):282-5. PubMed ID: 3895668
    [No Abstract]   [Full Text] [Related]  

  • 47. Cyclosporine-induced nephrotoxicity in patients with autoimmune uveitis.
    Palestine AG; Austin HA; Nussenblatt RB
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):209-14. PubMed ID: 3927536
    [No Abstract]   [Full Text] [Related]  

  • 48. Management and prevention of cyclosporine nephrotoxicity after renal transplantation: use of low doses of cyclosporine, azathioprine, and prednisone.
    Simmons RL; Canafax DM; Strand M; Ascher NL; Payne WD; Sutherland DE; Najarian JS
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):266-75. PubMed ID: 3895665
    [No Abstract]   [Full Text] [Related]  

  • 49. Cyclosporine-induced chronic nephropathy in human recipients of cardiac allografts.
    Moran M; Tomlanovich S; Myers BD
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):185-90. PubMed ID: 3895659
    [No Abstract]   [Full Text] [Related]  

  • 50. Nephrotoxicity of cyclosporine.
    N Engl J Med; 1986 Nov; 315(20):1291-2. PubMed ID: 3773944
    [No Abstract]   [Full Text] [Related]  

  • 51. "Cyclosporine-A nephrotoxicity in renal allograft recipients".
    Nix K; Plawecki HM
    J Nephrol Nurs; 1985; 2(5):220-2. PubMed ID: 3903104
    [No Abstract]   [Full Text] [Related]  

  • 52. Correlation of blood levels and tissue levels of cyclosporine with the histologic features of cyclosporine toxicity.
    Kumar MS; White AG; Alex G; Antos MS; Philips EM; Abouna GM
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):407-13. PubMed ID: 3363646
    [No Abstract]   [Full Text] [Related]  

  • 53. Abnormalities of arachidonate metabolism in experimental ciclosporin nephrotoxicity.
    Benigni A; Perico N; Remuzzi G
    Am J Nephrol; 1989; 9 Suppl 1():72-7. PubMed ID: 2493738
    [No Abstract]   [Full Text] [Related]  

  • 54. Vasodilatory prostaglandins and cyclosporin nephrotoxicity.
    Neild GH
    Prostaglandins Leukot Essent Fatty Acids; 1988; 33(3):207-12. PubMed ID: 3070570
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Morphology of cyclosporine nephrotoxicity in human heart transplant recipients.
    Chomette G; Auriol M; Beaufils H; Rottemburg J; Cabrol C
    J Heart Transplant; 1986; 5(4):273-8. PubMed ID: 3305818
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impaired fractional excretion of lithium: a very early marker of cyclosporine nephrotoxicity.
    Vincent HH; Wenting GJ; Schalekamp MA; Jeekel J; Weimar W
    Transplant Proc; 1987 Oct; 19(5):4147-8. PubMed ID: 3314004
    [No Abstract]   [Full Text] [Related]  

  • 57. Cyclosporine A nephrotoxicity: evidence for mesangial foam-cells in dogs.
    Blanc-Brunat N; Cochat P; Lang J; Hadj-Aissa A; Mutin M; Vivier G
    J Submicrosc Cytol; 1987 Jan; 19(1):149-54. PubMed ID: 3560286
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Calcium antagonist prevents nephrotoxicity.
    Br J Hosp Med; 1988 Jul; 40(1):78. PubMed ID: 3167298
    [No Abstract]   [Full Text] [Related]  

  • 59. Diagnosis of cyclosporine nephrotoxicity.
    Salaman JR
    Mt Sinai J Med; 1987 Sep; 54(6):457-9. PubMed ID: 3500401
    [No Abstract]   [Full Text] [Related]  

  • 60. Cyclosporine A nephrotoxicity in liver graft recipients: determination of nephrotoxic cyclosporine blood concentrations in liver graft recipients as defined by the HPLC and RIA tests.
    Hamilton G; Mühlbacher F; Roth E; Steininger R; Wolf I; Schindler J; Wolosczuk W; Piza F
    Transplant Proc; 1987 Oct; 19(5):4045-8. PubMed ID: 3313996
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.